Horgan Denis, Mia Rizwana, Erhabor Tosan, Hamdi Yosr, Dandara Collet, Lal Jonathan A, Fokom Domgue Joel, Ewumi Oladimeji, Nyawira Teresia, Meyer Salomé, Kondji Dominique, Francisco Ngiambudulu M, Ikeda Sadakatsu, Chuah Chai, De Guzman Roselle, Paul Anupriya, Reddy Nallamalla Krishna, Park Woong-Yang, Tripathi Vijay, Tripathi Ravikant, Johns Amber, Singh Mohan P, Phipps Maude E, Dube France, Whittaker Kate, Mukherji Deborah, Rasheed Hadi Mohamad Abu, Kozaric Marta, Pinto Joseph A, Doral Stefani Stephen, Augustovski Federico, Aponte Rueda Maria Eugenia, Fujita Alarcon Ricardo, Barrera-Saldana Hugo A
European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.
Healthcare (Basel). 2022 Oct 25;10(11):2125. doi: 10.3390/healthcare10112125.
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients' engagement, and efforts for a better understanding of cancer.
攻克癌症是全球面临的一项重大挑战。欧洲只是全球癌症问题的冰山一角。繁荣的发达国家也面临着困扰欧洲的同样问题，而资源较少、条件较差的国家和地区在许多情况下往往在英勇地与日益增长的疾病浪潮作斗争。本文就这些地域范围更广但本质上相似的挑战，以及在这场无休止的战斗中取得更好成果的前景和障碍提出了一种观点。欧洲个性化医疗联盟（EAPM）组织了一系列小组会议，以确定全球癌症护理的不同方面。在不同地区，诸如NGS、真实世界证据、分子诊断和报销等关键问题存在显著差异。总体而言，这导致了在医疗服务可及性、诊断、患者参与度以及增进对癌症理解的努力等方面的差异。
